Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
The provision of a vaccine to protect against Haemophilus influenzae type B (Hib) and meningitis C (MenC), to be used in the national childhood immunisation programme.
The contracting authority estimates their requirement over the period of the contract to be up to 3 000 000 doses.
Deliveries will be required over a period of 2 years.
Previously advised the market that a contract will be awarded for the supply of haemophilus influenza type b, meningococcal C vaccine (Hib/Men c), which has been concluded.
VEAT reference : 2019/S 187-454780
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| GlaxoSmithKline UK Ltd | 04310159 | ~£0 estimated from lot values | LOBBYIST Hill & Knowlton Limited (4 quarters) Global Counsel Ltd (1 quarter) |
Government spending data: This supplier has received £291,004,195 in 110 payments (over £25k) from UK Health Security Agency, Department of Health and Social Care (2021-01-21 to 2026-03-12). View full payment history →